• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 114.0
  • ISIN : INE059A01026
1,444.25 2 (0.14%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,429.00

  • Today’s High

    1,466.00

  • Open

    1,438.55

  • Perv Close

    1,442.20

  • 52W Low

    1,317.25

  • 52W High

    1,702.05

Key Indicators

  • P/E(TTM)

    25.07

  • Mar.Cap (₹Cr.)

    116,640.10

  • Div & Yield %

    0.90

  • Book Value(₹)

    360.74

  • Debt-Equity Ratio

    0.14

  • AGM Date

    01-Apr-2025

  • EPS

    57.63

  • P/E Ratio

    25.07

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    116,640.10

  • RONW (%)

    16.58

  • ROCE (%)

    22.27

Score Board

  • Equity (₹ in Cr.)

    161.52

  • BV (₹)

    360.70

  • Sales( ₹ in Cr.)

    16,574.34

  • NP (in Cr.)

    4,034.33

  • NP Var(%)

    58.0

  • Div%

    650.0

  • CPS (₹)

    57.20

  • EPS (₹)

    50.00

  • Traded Value (₹ in Lakhs)

    116,664.33

  • 52 Week High

    1,702.05

  • 52 Week Low

    1,317.25

  • Price BSE

    1445.0

  • Price NSE

    1,444.00

  • Market Capital( in Cr.)

    116,664.33

  • P/C Ratio

    25.20

  • P/E Ratio

    28.90

  • Price Vs.BV

    50.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 16,574.34 14,345.34 15,380.82 11,302.71 12,659.15 12,374.01
Excise Duty 15,924.20 14,690.14 15,052.48 11,060.17 12,220.22 11,968.44
Net Sales 16,574.34 14,345.34 15,380.82 11,302.71 12,659.15 12,374.01
Other Income 1,070.66 456.79 666.70 230.28 892.85 577.52
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 17,645.00 14,802.13 16,047.52 11,532.99 13,552.00 12,951.53
EXPENDITURE :
Raw Materials 15,924.20 14,690.14 15,052.48 11,060.17 12,220.22 11,968.44
Power & Fuel Cost 15,924.20 14,690.14 15,052.48 11,060.17 12,220.22 11,968.44
Employee Cost 2,644.21 2,335.69 2,113.78 1,703.58 1,911.08 1,839.84
Other Manufacturing Expenses 338.13 141.52 280.90 -291.15 452.66 367.11
Selling & Administrative Expenses 2,510.53 2,334.97 2,107.17 1,578.59 2,093.92 2,030.01
Miscellaneous Expenses 338.13 141.52 280.90 -291.15 452.66 367.11
Less : Pre-operative Expenses Capitalised :
Total Expenditure 12,698.03 11,610.63 12,243.14 8,748.99 10,587.69 10,458.70
Operating Profit 1,515.13 1,246.06 1,242.13 1,140.67 1,174.99 1,126.89
Interest 20.25 22.27 26.93 45.07 36.05 16.97
Gross Profit 4,946.97 3,005.60 3,804.38 2,784.00 2,964.31 2,492.83
Depreciation 587.59 595.91 546.62 468.62 599.78 569.72
Profit Before Tax 4,946.97 3,005.60 3,804.38 2,784.00 2,964.31 2,492.83
Tax 1,226.69 901.63 949.49 756.27 545.96 576.43
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.09 -40.09 -27.69 -16.92 100.18 27.99
Reported Net Profit 3,714.19 2,144.06 2,882.58 2,044.65 2,318.17 1,888.41
Extraordinary Items 4,946.97 3,005.60 3,804.38 2,784.00 2,964.31 2,492.83
Adjusted Net Profit 3,714.19 2,144.06 2,882.58 2,044.65 2,318.17 1,888.41
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 485.17 493.67 0.00 566.66 0.00 0.00
Statutory Appropriations 1,049.58 686.08 403.41 403.23 322.49 241.71
P & L Balance carried down 3,714.19 2,144.06 2,882.58 2,044.65 2,318.17 1,888.41
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 650.00 425.00 250.00 250.00 200.00 150.00
Dividend Per Share(Rs) 13.00 8.50 5.00 5.00 4.00 3.00
Earnings Per Share-Unit Curr 50.51 31.15 36.67 30.61 28.76 23.45
Book Value 1,049.58 686.08 403.41 403.23 322.49 241.71
Book Value(Adj)-Unit Curr 1,049.58 686.08 403.41 403.23 322.49 241.71

Shareholding Pattern

  • Promoter Group

    29.13%

  • Public Share Holding

    70.67%

  • Custodian

    0.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 161,460,683 161,460,683.00 161,460,683 161,460,683
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 161,460,683 19.99 161,460,683 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 73,826,320 9.14 73,826,320 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 73,826,320 9.14 73,826,320 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 32,912 0.00 32,912 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,528,707 0.19 1,526,582 14
Foreign Bank 17,600 0.00 17,500 3
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 214,793,145 26.60 214,793,145 946
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 41,089,131 5.09 41,089,131 32
Mutual Funds / UTI 164,938,926 20.42 164,938,926 40
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 15,811,611 1.96 15,811,611 40
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 438,212,032 54.26 438,209,807 1,077
2] Non Institution
Bodies Corporate 4,336,495 0.54 4,331,895 1,588
Clearing Members 88,517 0.01 88,517 13
Directors of their Relatives 336,036 0.04 336,036 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 8,014,651 0.99 6,722,701 13,241
Foreign Non Institution Other 375 0.00 375 1
Hindu Undivided Families 1,365,978 0.17 1,365,978 4,377
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 60,133,726 7.45 57,527,984 145
Individuals holding nominal share capital up to Rs. 1 lakh 55,036,254 6.81 53,341,321 504,640
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 590,107 0.07 590,107 23
Others 2,605,369 0.32 2,605,369 2
Sub Total 132,513,283 16.41 126,916,058 524,032
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 1,601,722 0.20 1,601,722 1
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 1,601,722 0.20 1,601,722 1
Grand Total ( A + B + C ) 807,614,040 100.00 802,014,590 525,114

Company Background

Cipla LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cipla Ltd
  • BSE Code : 114.0
  • ISIN : INE059A01026

  • Incorporation Year

    1935

  • Registered Office

    Cipla House Peninsula Buss Par
    Ganpatrao Kadam Mg Lower Parel, Mumbai,
    Maharashtra-400013

  • Telephone

    91-22-24826000

  • FAX

    91-22-24826120

  • Chairman

    Y K Hamied

  • Managing Director

    Umang Vohra

  • Company Secretary

    Rajendra Chopra

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cipla Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Novartis India 807.65 396.75 335.07 23.12 15.57
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92